3728 Jinke Rd, Building 1, West Wing, Shanghai, China
info@tyligand.com
Our Focus
Therapeutic Areas
We aim to build an efficient engine for small molecule innovation and a research pipeline for cancer diseases, providing global patients with safer, more effective, and more accessible treatment options.
Cancer has become one of the leading causes of death and a major healthcare burden. We focus on the molecular mechanisms of carcinogenesis and the characteristics of tumor microenvironment, and are committed to discovering drugs that can help to regulate the expression of oncogenes and their signaling pathways, disrupt the tumor microenvironment, and restore immune normalcy.